These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 8346490

  • 1. Time course and duration of bronchodilatation with formoterol dry powder in patients with stable asthma.
    Wallin A, Sandström T, Rosenhall L, Melander B.
    Thorax; 1993 Jun; 48(6):611-4. PubMed ID: 8346490
    [Abstract] [Full Text] [Related]

  • 2. [Changes in specific airway resistance after powder inhalation of formoterol or salmeterol in moderate bronchial asthma].
    Sill V, Bartuschka B, Villiger B, Ortland C, Domej W.
    Pneumologie; 1999 Jan; 53(1):4-9. PubMed ID: 10091511
    [Abstract] [Full Text] [Related]

  • 3. Formoterol as dry powder oral inhalation compared with salbutamol metered-dose inhaler in acute exacerbations of chronic obstructive pulmonary disease.
    Cazzola M, D'Amato M, Califano C, Di Perna F, Calderaro E, Matera MG, D'Amato G.
    Clin Ther; 2002 Apr; 24(4):595-604. PubMed ID: 12017404
    [Abstract] [Full Text] [Related]

  • 4. Time course of bronchodilating effect of inhaled formoterol, a potent and long acting sympathomimetic.
    Derom EY, Pauwels RA.
    Thorax; 1992 Jan; 47(1):30-3. PubMed ID: 1539141
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A randomized, 12-week, double-blind, placebo-controlled study comparing formoterol dry powder inhaler with albuterol metered-dose inhaler.
    Bensch G, Lapidus RJ, Levine BE, Lumry W, Yegen U, Kiselev P, Della Cioppa G.
    Ann Allergy Asthma Immunol; 2001 Jan; 86(1):19-27. PubMed ID: 11206232
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Evaluation of different doses of formoterol from a newly developed powder inhalation device in asthmatic patients.
    van den Berg BT, Smeets JJ, van Boxtel CJ, Maesen FP.
    Fundam Clin Pharmacol; 1995 Jan; 9(6):593-603. PubMed ID: 8808181
    [Abstract] [Full Text] [Related]

  • 12. Formoterol, a new long-acting selective beta 2-adrenergic receptor agonist: double-blind comparison with salbutamol and placebo in children with asthma.
    Becker AB, Simons FE.
    J Allergy Clin Immunol; 1989 Dec; 84(6 Pt 1):891-5. PubMed ID: 2574732
    [Abstract] [Full Text] [Related]

  • 13. Formoterol delivered via the dry powder Aerolizer inhaler versus albuterol MDI and placebo in mild-to-moderate asthma: a randomized, double-blind, double-dummy trial.
    Pleskow W, LaForce CF, Yegen U, Matos D, Della Cioppa G.
    J Asthma; 2003 Dec; 40(5):505-14. PubMed ID: 14529100
    [Abstract] [Full Text] [Related]

  • 14. Formoterol fumarate, a new beta 2-adrenoceptor agonist. Acute studies of selectivity and duration of effect after inhaled and oral administration.
    Löfdahl CG, Svedmyr N.
    Allergy; 1989 May; 44(4):264-71. PubMed ID: 2544117
    [Abstract] [Full Text] [Related]

  • 15. Efficacy, tolerability, and effect on asthma-related quality of life of formoterol bid via multidose dry powder inhaler and albuterol QID via metered dose inhaler in patients with persistent asthma: a multicenter, randomized, double-blind, double-dummy, placebo-controlled, parallel-group study.
    Busse W, Levine B, Andriano K, Lavecchia C, Yegen U.
    Clin Ther; 2004 Oct; 26(10):1587-98. PubMed ID: 15598475
    [Abstract] [Full Text] [Related]

  • 16. Preventive effects of inhaled formoterol and salbutamol on histamine-induced bronchoconstriction--a placebo-controlled study.
    Sovijärvi AR, Reinikainen K, Freudenthal Y, Andersson P, Riska H.
    Respiration; 1992 Oct; 59(5):279-82. PubMed ID: 1488561
    [Abstract] [Full Text] [Related]

  • 17. Onset of relief of dyspnoea with budesonide/formoterol or salbutamol following methacholine-induced severe bronchoconstriction in adults with asthma: a double-blind, placebo-controlled study.
    Jonkers RE, Bantje TA, Aalbers R.
    Respir Res; 2006 Dec 04; 7(1):141. PubMed ID: 17144916
    [Abstract] [Full Text] [Related]

  • 18. Duration of action of formoterol and salbutamol dry-powder inhalation in prevention of exercise-induced asthma in children.
    Daugbjerg P, Nielsen KG, Skov M, Bisgaard H.
    Acta Paediatr; 1996 Jun 04; 85(6):684-7. PubMed ID: 8816204
    [Abstract] [Full Text] [Related]

  • 19. Onset and duration of action of single doses of formoterol inhaled via Turbuhaler.
    Ringdal N, Derom E, Wåhlin-Boll E, Pauwels R.
    Respir Med; 1998 Aug 04; 92(8):1017-21. PubMed ID: 9893769
    [Abstract] [Full Text] [Related]

  • 20. Long duration of airway but not systemic effects of inhaled formoterol in asthmatic patients.
    Lötvall J, Ankerst J.
    Respir Med; 2008 Mar 04; 102(3):449-56. PubMed ID: 18023335
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.